Trials / NCT06982417
InsightRP2 Registry
Recruiting now Observational Natural history / observational
- Sponsor
- University of Göttingen
- Treatment
- Not listed
- Gene
- RP2
- Conditions
- RP2-associated Retinitis Pigmentosa, X-Linked Retinitis Pigmentosa (XLRP), Retinitis Pigmentosa 2
- Ages
- Any to no upper limit
- Enrollment
- 200 participants
- Started
- 2025-05-01
- Main results expected
- 2045-05-01
- Results posted
- Not yet
- Record last updated
- 2025-05-21
What the study is testing
InsightRP2 is a secure online patient registry specific to RP2-associated retinitis pigmentosa (RP). It is our goal to further the scientific understanding of this rare disease and to support research in to a gene therapy for RP2-associated RP.
We collect medical, genetic and imaging data from people affected by RP2-associated RP and will coduct a natural history study as well as image analysis studies.
Where it runs
Germany (1)
- University Medicine Göttingen, Göttingen, Lower Saxony (recruiting now)